National Healthcare NHC
- Market cap
- $3.7B
- PE
- 26.5×
- 10y median 21.4×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.4×
- EV/EBIT
- 23.8×
- Revenue, 12 months
- $1.6B
- +7% on a year ago
- Net margin
- 9.0%
- Free cash flow yield
- 4.0%
National Healthcare trades at 26.5× trailing earnings, pricier than 71% of the last ten years. Revenue was $1.6B over the last twelve months, up 7% on a year earlier with a 9% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $288.5M+7% | $300.9M+14% | $297.2M+10% | $300.7M+6% | $340.2M+18% | $369.4M+23% | $373.7M+26% | $374.9M+25% | $382.7M+13% | $386.5M+5% | $381.8M+2% | $408M+9% | |
| $13M+219% | $20.1M+122% | $15.7M+57% | $22.5M+61% | $22.8M+75% | $28.9M+44% | $30.8M+96% | $34.1M+51% | $30.4M+33% | $33.1M+15% | $32.3M+5% | $48.9M+44% | |
| Interest expense | $77K−44% | $56K−50% | $46K−53% | $0 | $1.7M+2162% | $2.3M+4091% | $2.1M+4478% | $2M | $1.5M−16% | $816K−65% | $269K−87% | $13K−99% |
| Pre-tax income | $14M | $36.7M+395% | $35.7M+127% | $36.6M+64% | $58M+314% | $6.1M−84% | $43.7M+22% | $32.2M−12% | $54.4M−6% | $32.1M+431% | $44.8M+3% | $54M+68% |
| $3.9M | $8.7M+373% | $9.5M+113% | $9.5M+48% | $15.3M+293% | $28K−100% | $11.4M+21% | $8.1M−15% | $13.4M−13% | $6.9M+24682% | $8.7M−24% | $13.5M+67% | |
| Net income | $10.4M | $28.4M+347% | $26.2M+124% | $26.8M+65% | $42.8M+312% | $6.1M−79% | $32.2M+23% | $23.7M−12% | $39.2M−8% | $24.8M+309% | $35.9M+11% | $40.3M+70% |
| $0.68 | $1.83+346% | $1.69+122% | $1.73+63% | $2.73+302% | $0.39−79% | $2.07+23% | $1.52−12% | $2.50−8% | $1.58+305% | $2.27+10% | $2.54+67% | |
| 15.3M−1% | 15.5M+1% | 15.5M+1% | 15.6M+2% | 15.7M+2% | 15.7M+1% | 15.6M+1% | 15.6M+0% | 15.7M+0% | 15.7M+1% | 15.8M+1% | 15.9M+2% |
EPS, diluted: 10 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 16 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest National Healthcare's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| NHCNational Healthcare | $3.7B | 26.5× | 21.4× | 2.4× | +7% | 9.0% | |
| OPCHOption Care Health | $4.7B | 23.5× | 26.4× | 0.8× | +6% | 3.7% | |
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | 3.1× | +20% | 3.2% | |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | 2.2× | +14% | 8.7% | |
| SHCSotera Health | $5.2B | 31.8× | 55.4× | 4.2× | +8% | 13.4% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| PGNYProgyny | $2.2B | 31.5× | 55.1× | 1.7× | +6% | 6.0% | |
| CHEChemed | $6.7B | 25.8× | 29.0× | 2.6× | +3% | 10.6% | |
| Peer median | $3.8B | 25.6× | 30.7× | 1.6× | +11% | 7.9% |
More on National Healthcare
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #8of 42Hospital and care facility stocks with the highest profit margins
- #8of 21Hospital and care facility stocks with the fastest earnings growth
- #10of 11Hospital and care facility stocks cheapest against their own PE history
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .